# STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study

> **NCT01181505** · PHASE1 · COMPLETED · sponsor: **Inje University** · enrollment: 31 (actual)

## Conditions studied

- Genotype Guided(HNF4a)
- Healthy Subjects

## Interventions

- **DRUG:** Tolterodine

## Key facts

- **NCT ID:** NCT01181505
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2010-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181505, "STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01181505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*